Table 1.
Uptake (n and %) of Continuous Subcutaneous Insulin Infusion (CSII) therapy in people with type 1 diabetes in Ireland in 2016
| Age Group (Years) | CSII therapy users (Total numbers) | People with type 1 diabetes (total numbers) | % Uptake of CSII | 95% CI |
|---|---|---|---|---|
| 0–14 | 702 | 1846 | 38.0% | 35.8 to 40.2% |
| 15–24 | 417 | 2182 | 19.1% | 17.5 to 20.8% |
| 25–34 | 239 | 2363 | 10.1% | 8.9 to 11.3% |
| 35–44 | 277 | 2831 | 9.8% | 8.7 to 10.9% |
| 45–54 | 235 | 2897 | 8.1% | 7.1 to 9.1% |
| 55–64 | 121 | 2889 | 4.2% | 3.5 to 4.9% |
| 65–74 | 55 | 2688 | 2.1% | 1.5 to 2.6% |
| 75+ | 15 | 1948 | 0.8% | 0.4 to 1.2% |
| TOTAL | 2111a | 20,081b | 10.5% | 10.1 to 10.9% |
| < 18 years | 899 | 2591 | 34.7% | 32.9 to 36.5% |
| ≥18 years | 1162 | 17,053 | 6.8% | 6.4 to 7.2% |
aThere were 50 missing data for age (2%) in the uptake of insulin pumps
bThere were 437 missing data for age (2%) in the prevalence of type 1 diabetes